ESC 365 - Nivolumab associated myasthenia gravis with severly elevated cardiac biomarkers: to treat or not to treat?

HFA Premium Access

Nivolumab associated myasthenia gravis with severly elevated cardiac biomarkers: to treat or not to treat?

Session: Clinical Case Award

Topic: Cardio-Oncology

Speaker: Doctor E. Haegler-Laube (Bern, CH)

Event: Heart Failure 2021

Congress Presentation

About the speaker

Doctor Eva Haegler-Laube

Bern University Hospital, Inselspital, Bern (Switzerland)

2 presentations

0 follower

3 more presentations in this session

Acute heart failure secondary to Multisystem Inflammatory Syndrome in Adults (MIS-A) temporally associated with asymptomatic SARS-CoV-2 infection.

Speaker: Doctor S. Hobson (Glasgow, GB)

Never Too Late to be Just in Time: Fulminant Giant Cell Myocarditis.

Speaker: Doctor J. Morris (Salford, GB)

Severe ventricular dysfunction due to a catecholamine-secreting paraganglioma.

Speaker: Mr L. Dominguez Rodriguez (Vigo, ES)

Access the full session

Clinical Case Award

Speakers: Doctor E. Haegler-Laube, Doctor S. Hobson, Doctor J. Morris, Mr L. Dominguez Rodriguez

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by